A medical expert underscores the significance of infertility treatment coverage.
This expert perspective, provided by Joseph Chervenak, MD, MBA, illustrates the significant impact of infertility treatment coverage on decision-making, particularly in resource-limited populations. The focus is on the spectrum of infertility care, emphasizing alternatives to expensive treatments like IVF, such as oral medications (Clomid, letrozole) and intrauterine insemination (IUI). The influence of insurance mandates, requiring specific cycles of IUI before IVF, poses challenges for patients, affecting the success of the process, especially with aging. The introduction of frozen embryo transfer (FET) allows flexibility in timing, but insurance specifications play a role, with some requiring transfers within a specific timeframe. The evolving practice of vitrification for eggs and embryos raises questions about patient choices, including fertilization and potential options like donation or discarding. The complexity of these issues underscores the individualized nature of fertility treatments and the impact of external factors on patients' choices and outcomes.
Video synopsis is AI-generated and reviewed by Managed Health Care Executive editorial staff.
Evolving Role of Statins in Managing CV Risk in HIV | ID Week 2024
October 18th 2024Statins have had an evolving role in the management of cardiovascular risk in people living with HIV, explained Michelle Cespedes, M.D., M.S., professor of medicine, Icahn School of Medicine at Mount Sinai and Mount Sinai Health System.
Read More